Literature DB >> 14749497

Functional significance of Tie2 signaling in the adult vasculature.

Kevin G Peters1, Christopher D Kontos, P Charles Lin, Adrianne L Wong, Prema Rao, Liwen Huang, Mark W Dewhirst, Sabita Sankar.   

Abstract

Abundant data now demonstrate that the growth of new blood vessels, termed angiogenesis, plays both pathological and beneficial roles in human disease. Based on these data, a tremendous effort has been undertaken to understand the molecular mechanisms that drive blood vessel growth in adult tissues. Tie2 recently was identified as a receptor tyrosine kinase expressed principally on vascular endothelium. Disrupting Tie2 function in mice resulted in embryonic lethality with defects in embryonic vasculature, suggesting a role in blood vessel maturation and maintenance. Based on these studies, we undertook a series of studies to probe the function of Tie2 in adult vasculature that will form the focus of this chapter. Consistent with a role in blood vessel growth in adult vasculature, Tie2 was upregulated and activated in the endothelium of rat ovary and in healing rat skin wounds, both areas of active angiogenesis. Moreover, Tie2 was upregulated in the endothelium of vascular "hot spots" in human breast cancer specimens. Surprisingly, Tie2 also was expressed and activated in the endothelium of all normal rat tissues examined, suggesting a role in maintenance of adult vasculature. To determine the functional role of Tie2 in tumor vasculature, a soluble Tie2 extracellular domain (ExTek) was designed that blocked the activation of Tie2 by its activating ligand, angiopoietin 1 (Ang1). Administration of recombinant ExTek protein or an ExTek adenovirus inhibited tumor growth and metastasis in rodent tumor models, demonstrating a functional role for Tie2 in pathological angiogenesis in adult tissues. To begin to understand the endothelial signaling pathways and cellular responses that mediate Tie2 function, we identified signaling molecules that are recruited to the activated, autophosphorylated Tie2 kinase domain. Two of these molecules, SHP2 and GRB2, are part of the pathway upstream of mitogen-activated protein kinase (MAPK) activation, a pathway that may be responsible for morphogenetic effects of Tie2 on endothelial cells. Another signaling molecule, p85, is responsible for recruitment of phosphatidylinositol 3 kinase (PI3-K) and activation of the Akt/PI3-K pathway. Akt/PI3-K has emerged as a critical pathway downstream of Tie2 that is necessary for cell survival effects as well as for chemotaxis, activation of endothelial nitric oxide synthase, and perhaps for anti-inflammatory effects of Tie2 activation. Taken together, these studies and many others demonstrate that the Tie2 pathway has important functions in adult tissues, in both quiescent vasculature and during angiogenesis, and help to validate the Tie2 pathway as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749497     DOI: 10.1210/rp.59.1.51

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  62 in total

Review 1.  In vitro models for the evaluation of angiogenic potential in bone engineering.

Authors:  Elisabetta Cenni; Francesca Perut; Nicola Baldini
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

2.  ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.

Authors:  Maren Cam; Manish Charan; Alessandra M Welker; Piyush Dravid; Adam W Studebaker; Jeffrey R Leonard; Christopher R Pierson; Ichiro Nakano; Christine E Beattie; Eugene I Hwang; Madhuri Kambhampati; Javad Nazarian; Jonathan L Finlay; Hakan Cam
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

3.  Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.

Authors:  Hareesh B Nair; Rao P Perla; Nameer B Kirma; Naveen K Krishnegowda; Manonmani Ganapathy; Rajib Rajhans; Sujit S Nair; Pothana Saikumar; Ratna K Vadlamudi; Rajeshwar Rao Tekmal
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

4.  High Expression of Angiopoietin-1 is Associated with Lymph Node Metastasis and Invasiveness of Papillary Thyroid Carcinoma.

Authors:  Yea Eun Kang; Koon Soon Kim; Sung Jae Park; Seung-Nam Jung; Jae Won Chang; Shinae Yi; Min Gyu Jung; Jin-Man Kim; Bon Seok Koo
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

5.  Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch.

Authors:  Sujata Rao; Ivan B Lobov; Jefferson E Vallance; Kaoru Tsujikawa; Ichiro Shiojima; Shailaja Akunuru; Kenneth Walsh; Laura E Benjamin; Richard A Lang
Journal:  Development       Date:  2007-12       Impact factor: 6.868

6.  Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice.

Authors:  Xianghu Qu; Kevin Tompkins; Lorene E Batts; Mira Puri; H Scott Baldwin; Scott Baldwin
Journal:  Development       Date:  2010-03-10       Impact factor: 6.868

7.  The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration.

Authors:  Guanqiao Li; Ulka Sachdev; Kevin Peters; Xiaoyan Liang; Michael T Lotze
Journal:  J Immunother       Date:  2019-09       Impact factor: 4.456

8.  Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study.

Authors:  Carlos Iribarren; Bruce H Phelps; Jeanne A Darbinian; Edward R McCluskey; Charles P Quesenberry; Evangelos Hytopoulos; Joseph H Vogelman; Norman Orentreich
Journal:  BMC Cardiovasc Disord       Date:  2011-06-14       Impact factor: 2.298

Review 9.  Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.

Authors:  Shigetomo Fukuhara; Keisuke Sako; Kazuomi Noda; Kaori Nagao; Koichi Miura; Naoki Mochizuki
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

10.  Cellular therapy for repair of cardiac damage after acute myocardial infarction.

Authors:  Matthew M Cook; Katarina Kollar; Gary P Brooke; Kerry Atkinson
Journal:  Int J Cell Biol       Date:  2009-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.